Gulam A Manji

4PUBLICATIONS
37CO-AUTHORS
ChemotherapyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 29, 2026
Motixafortide, cemiplimab, gemcitabine and nab-paclitaxel in metastatic pancreatic cancer: a single-arm phase 2 study with single-cell correlatives.

|Aug 26, 2026
Developmental and MAPK-responsive transcription factors regulate distinct malignant cell states and associated genetic dependencies in pancreatic cancer.

|Mar 30, 2026
Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trial.

Zev A Wainberg, Gulam A Manji, Nathan Bahary

|Oct 28, 2025
Cellular states associated with metastatic organotropism and survival in patients with pancreatic ductal adenocarcinoma.

Morteza Chalabi Hajkarim, Michael May, Amit Dipak Amin

Pageof 1

Frequent Collaborators

2 joint publications

Edridge K D'Souza

2 joint publications

Benjamin Izar

2 joint publications

Somnath Tagore

1 joint publications

Morteza Chalabi Hajkarim